Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2020

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of fair value assumptions of stock option granted

	Year Ended December 31,
	2020			2019
Dividend yield		0.00	%		0.00	%
Risk-free interest rate	0.28—0.46		%		1.49	%
Expected term (years)	5.65—6.13				5.65
Volatility	92.51—107.87		%		93.72	%

Schedule of RSA activity

	Number of Shares			Weighted Average Grant Date Fair Value
Unvested, December 31, 2019		450,000		$	0.19
Granted		—			—
Released		(450,000	)		0.19
Unvested, December 31, 2020		—		$	—

Schedule of stock-Based compensation Expense

	Year Ended December 31,
	2020		2019
Research and development	$	93,545	$	—
General and administrative		209,197		680,455
	$	302,742	$	680,455

Stock options | Omnibus Incentive Plan 2014

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of shares available for future grant

Shares Available for Grant
Available as of December 31, 2019	13,128,381
Share pool increase	18,394,752
Forfeited	1,837,407
Cancelled	5,830,235
Granted	(26,400,000	)
Available as of December 31, 2020	12,790,775

Schedule of summary of stock option activity

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value*
Outstanding, December 31, 2019		3,317,642		$	0.33		8.34
Granted		26,400,000			0.05
Cancelled		(5,830,235	)		0.07
Forfeited		(1,837,407	)		0.26
Outstanding, December 31, 2020		22,050,000		$	0.06		9.52	$	—
Exercisable, December 31, 2020		3,465,000		$	0.15		8.88	$	—
Vested and expected to vest, December 31, 2020		22,050,000		$	0.06		9.52	$	—

*The aggregate intrinsic value is the sum of the amounts by which the quoted market price of the Company’s stock exceeded the exercise price of the stock options at December 31, 2020 for those stock options for which the quoted market price was in excess of the exercise price (“in-the-money options”).